These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 7783651

  • 21. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.
    Larosche I, Lettéron P, Fromenty B, Vadrot N, Abbey-Toby A, Feldmann G, Pessayre D, Mansouri A.
    J Pharmacol Exp Ther; 2007 May; 321(2):526-35. PubMed ID: 17277197
    [Abstract] [Full Text] [Related]

  • 22. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
    Sozio MS, Liangpunsakul S, Crabb D.
    Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
    [Abstract] [Full Text] [Related]

  • 23. Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis.
    Morris EM, McCoin CS, Allen JA, Gastecki ML, Koch LG, Britton SL, Fletcher JA, Fu X, Ding WX, Burgess SC, Rector RS, Thyfault JP.
    J Physiol; 2017 Jul 15; 595(14):4909-4926. PubMed ID: 28504310
    [Abstract] [Full Text] [Related]

  • 24. Breath tests with novel 13C-substrates for clinical studies of liver mitochondrial function in health and disease.
    Grattagliano I, Bonfrate L, Oliveira PJ, Castorani L, Ruggiero V, Valenzano AT, Ascensão A, Buzoianu A, Portincasa P.
    Eur Rev Med Pharmacol Sci; 2013 Jul 15; 17 Suppl 2():72-81. PubMed ID: 24443072
    [Abstract] [Full Text] [Related]

  • 25. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK, Nik Mustapha NR, Mahadeva S.
    J Gastroenterol Hepatol; 2014 Jul 15; 29(7):1470-6. PubMed ID: 24548002
    [Abstract] [Full Text] [Related]

  • 26. Acute valproate-associated microvesicular steatosis: could the [13C]methionine breath test be useful to assess liver mitochondrial function?
    Spahr L, Negro F, Rubbia-Brandt L, Marinescu O, Goodman K, Jordan M, Frossard JL, Hadengue A.
    Dig Dis Sci; 2001 Dec 15; 46(12):2758-61. PubMed ID: 11768270
    [Abstract] [Full Text] [Related]

  • 27. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
    Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M.
    Am J Surg Pathol; 2012 May 15; 36(5):710-5. PubMed ID: 22498821
    [Abstract] [Full Text] [Related]

  • 28. Decarboxylation of alpha-ketoisovaleric acid after oral administration in man.
    Epstein CM, Chawla RK, Wadsworth A, Rudman D.
    Am J Clin Nutr; 1980 Sep 15; 33(9):1968-74. PubMed ID: 6774606
    [Abstract] [Full Text] [Related]

  • 29. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I, Lee JM, Lee KB, Yoon JH, Kiefer B, Han JK, Choi BI.
    Radiology; 2014 Jun 15; 271(3):730-8. PubMed ID: 24533869
    [Abstract] [Full Text] [Related]

  • 30. Exploring liver mitochondrial function by ¹³C-stable isotope breath tests: implications in clinical biochemistry.
    Grattagliano I, Bonfrate L, Lorusso M, Castorani L, de Bari O, Portincasa P.
    Methods Mol Biol; 2015 Jun 15; 1241():137-52. PubMed ID: 25308494
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb 15; 306(4):G320-7. PubMed ID: 24356885
    [Abstract] [Full Text] [Related]

  • 32. Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations.
    Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, Schwartz P, Magnuson T, Diehl AM, Risby TH.
    Biomarkers; 2006 Feb 15; 11(2):174-83. PubMed ID: 16766393
    [Abstract] [Full Text] [Related]

  • 33. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test.
    Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, Gasbarrini G.
    Am J Gastroenterol; 2003 Oct 15; 98(10):2335-6. PubMed ID: 14572600
    [No Abstract] [Full Text] [Related]

  • 34. Oxidation of branched-chain amino acids in skeletal muscle and liver of rat. Effects of octanoate and energy state.
    Spydevold O, Hokland B.
    Biochim Biophys Acta; 1981 Sep 04; 676(3):279-88. PubMed ID: 6793084
    [Abstract] [Full Text] [Related]

  • 35. Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.
    Item F, Wueest S, Lemos V, Stein S, Lucchini FC, Denzler R, Fisser MC, Challa TD, Pirinen E, Kim Y, Hemmi S, Gulbins E, Gross A, O'Reilly LA, Stoffel M, Auwerx J, Konrad D.
    Nat Commun; 2017 Sep 07; 8(1):480. PubMed ID: 28883393
    [Abstract] [Full Text] [Related]

  • 36. Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis.
    Lockman KA, Baren JP, Pemberton CJ, Baghdadi H, Burgess KE, Plevris-Papaioannou N, Lee P, Howie F, Beckett G, Pryde A, Jaap AJ, Hayes PC, Filippi C, Plevris JN.
    Liver Int; 2012 Aug 07; 32(7):1079-92. PubMed ID: 22429485
    [Abstract] [Full Text] [Related]

  • 37. The evaluation of the repeatability of the 13C-ketoisocaproate breath test for assessing hepatic mitochondrial function.
    Afolabi PR, Scorletti E, Calder PC, Byrne CD.
    Isotopes Environ Health Stud; 2019 May 07; 55(2):150-160. PubMed ID: 30880467
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of glycine oxidation by pyruvate, alpha-ketoglutarate, and branched-chain alpha-keto acids in rat liver mitochondria: presence of interaction between the glycine cleavage system and alpha-keto acid dehydrogenase complexes.
    Kochi H, Seino H, Ono K.
    Arch Biochem Biophys; 1986 Sep 07; 249(2):263-72. PubMed ID: 3753002
    [Abstract] [Full Text] [Related]

  • 39. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease.
    Oliveira CP, Coelho AM, Barbeiro HV, Lima VM, Soriano F, Ribeiro C, Molan NA, Alves VA, Souza HP, Machado MC, Carrilho FJ.
    Braz J Med Biol Res; 2006 Feb 07; 39(2):189-94. PubMed ID: 16470305
    [Abstract] [Full Text] [Related]

  • 40. Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice.
    Berge RK, Bjørndal B, Strand E, Bohov P, Lindquist C, Nordrehaug JE, Svardal A, Skorve J, Nygård O.
    Lipids Health Dis; 2016 Feb 05; 15():24. PubMed ID: 26846427
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.